The Tranexamic Acid Pill for Melasma: Off-Label, but Backed by Real Evidence

Melasma, the blotchy brown patches that settle on cheeks, forehead and upper lip, is one of the most frustrating skin problems there is: driven by hormones and sunlight, quick to return, and stubborn against creams. One of the more surprising treatments is an old, cheap tablet called tranexamic acid, normally used to control bleeding. Taken in a low dose it can meaningfully fade melasma, and the evidence is better than most people realise. Because it is off-label, though, there is little official guidance, so here is a clear look.

In short

• Tranexamic acid (TXA) is an anti-bleeding drug that, at low oral doses, has a well-documented off-label effect on melasma.
• Studies use around 250 to 500 mg twice daily, with clear improvement over a few months.
• One trial reported a 65 percent reduction in a standard melasma severity score; results build gradually, not overnight.
• The big worry, blood clots, has not shown up in the melasma dose in a large real-world study, though caution still applies to people at higher clot risk.
• It treats the pigment, not the cause: sun protection is non-negotiable, or the melasma returns.

How does a bleeding drug fade melasma?

Tranexamic acid appears to calm the interaction between blood vessels and pigment-producing cells in the skin, reducing the overproduction of melanin that drives melasma. It was designed to help blood clot, which is why it treats heavy periods and surgical bleeding, but researchers noticed it also lightened pigmentation. The current understanding is that it dampens the signals, partly vascular, that push melanocytes to overproduce pigment. That is a different mechanism from a lightening cream, which is why it can help when topicals alone stall. You can read the drug's fuller profile on our tranexamic acid page.

What dose is used and how fast does it work?

Low oral doses, commonly 250 to 500 mg twice a day, with visible improvement over roughly three months. This is well below the dose used to stop heavy bleeding. In a randomised comparison summarised in this PMC trial, oral tranexamic acid produced significant fading, and one study reported a 65 percent drop in the MASI score, the standard melasma severity measure, by three months. It is a slow burn, not a quick fix, and because melasma relapses, dermatologists often use it in courses rather than indefinitely.

Is the blood-clot risk real?

It is the right question to ask, but at the low melasma dose the feared clot risk has not materialised in the data, while still warranting caution in higher-risk people. Tranexamic acid promotes clotting by design, so the theoretical concern is deep vein thrombosis or similar. Reassuringly, a large multicentre study matching thousands of records found that oral tranexamic acid use for melasma was not associated with thromboembolism, reported in this PMC cohort. That does not make it risk-free for everyone: a personal or family history of clots, clotting disorders, or use of the combined contraceptive pill changes the calculation, and that screening is exactly why it should run through a doctor rather than be bought blind.

Does it replace creams and sun protection?

No. It works alongside them, and without daily sun protection the melasma comes back no matter what pill you take. Melasma is powered by ultraviolet and visible light, so broad-spectrum sunscreen and sun avoidance are the foundation everything else sits on. Tranexamic acid is best seen as an add-on for stubborn cases, often combined with topical treatments and pigment-focused skincare. Skipping the sun step is the single most common reason treatment disappoints. Browse the skin care range to see the topical side.

Who is it not for?

People with a history of blood clots, certain clotting conditions, or specific cardiovascular risks, which is why screening matters. Anyone who has had a DVT or pulmonary embolism, has a known clotting disorder, or is on medicines that raise clot risk needs a proper assessment before starting. Pregnancy is another situation for caution. None of this is a reason for most people to avoid it, but it is the reason a prescriber checks first. This is a genuine off-label medicine, not a cosmetic.

The bottom line

Tranexamic acid is a real, evidence-backed option for melasma that too few people know about, precisely because it is off-label and under-discussed by official sources. Used at a low dose, with sun protection and often alongside creams, it can fade patches that resist everything else, and the clot worry, while worth screening for, has not borne out at this dose. Treat it as a medicine, get it checked, and pair it with relentless sun care.

This article is educational and does not replace advice from a doctor or pharmacist who knows your health history.